Vincent Huberlant

Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study

Alexandre Mebazaa, Christopher Geven, Alexa Hollinger et al. · Critical Care · 2018 · 134 citations · Full text

Veterinary Medicine, Internal Medicine, Critical Care Pharmacology +16

Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study

Alexa Hollinger, Xavier Wittebole, Bruno François et al. · Kidney International Reports · 2018 · 107 citations · Full text

Veterinary Medicine, Nephrology, Renal Pathophysiology +16

Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial

Jean Chastre, Bruno François, Marc Bourgeois et al. · Critical Care · 2022 · 93 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17

Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial

Pierre‐François Laterre, Peter Pickkers, Gernot Marx et al. · Intensive Care Medicine · 2021 · 92 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +15

Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial

Bruno François, Hasan S. Jafri, Jean Chastre et al. · The Lancet Infectious Diseases · 2021 · 87 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +11